Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten… - Nephrology Dialysis …, 2003 - academic.oup.com
Background. Patients with chronic renal failure commonly suffer from a secondary form of
complex dyslipidaemia, and may benefit from lipid‐lowering treatment. Atorvastatin has …
被引用次数：171 相关文章

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.

RL Lins, KE Matthys, GA Verpooten… - … : Official Publication of …, 2003 - europepmc.org
BACKGROUND: Patients with chronic renal failure commonly suffer from a secondary form
of complex dyslipidaemia, and may benefit from lipid-lowering treatment. Atorvastatin has …
[PDF] psu.edu

[PDF][PDF] Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten, PC Peeters… - Nephrol Dial …, 2003 - Citeseer
Background. Patients with chronic renal failure commonly suffer from a secondary form of
complex dyslipidaemia, and may benefit from lipid-lowering treatment. Atorvastatin has been …

[引用][C] Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten… - Nephrology …, 2003 - repository.uantwerpen.be
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in
hypercholesterolaemic haemodialysis patients - Institutional Repository University of …

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten… - Nephrology Dialysis …, 2003 - elibrary.ru
Background.? Patients with chronic renal failure commonly suffer from a secondary form of
complex dyslipidaemia, and may benefit from lipid‐lowering treatment. Atorvastatin has …

[引用][C] Pharmacokineties of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL LINS, KE MATTHYS, GA VERPOOTEN… - NEPHROLOGY …, 2003 - biblio.ugent.be
Pharmacokineties of atorvastatin and its metabolites after single and multiple dosing in
hypercholesterolaemic haemodialysis patients Universiteit Gent Add publications and …
[PDF] academia.edu

[PDF][PDF] Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten… - Nephrol Dial …, 2003 - academia.edu
Background. Patients with chronic renal failure commonly suffer from a secondary form of
complex dyslipidaemia, and may benefit from lipid-lowering treatment. Atorvastatin has been …

[引用][C] Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

R Lins, K Matthys, G Verpooten, P Peeters… - Nephrology, dialysis …, 2003 - difusion.ulb.ac.be

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

RL Lins, KE Matthys, GA Verpooten… - … publication of the …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Patients with chronic renal failure commonly suffer from a secondary form of
complex dyslipidaemia, and may benefit from lipid-lowering treatment. Atorvastatin has been …

[引用][C] Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

L RL - Nephrol Dial Transplant, 2003 - cir.nii.ac.jp
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in
hypercholesterolaemic haemodialysis patients | CiNii Research CiNii 国立情報学研究所 学術 …